Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v5-FR
Language French French
Date Updated 2017-08-22 2017-04-25
Drug Identification Number 02411644 02411644
Brand name ROSUVASTATIN-20 ROSUVASTATIN-20
Common or Proper name ROSUVASTATIN-20 ROSUVASTATIN-20
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients ROSUVASTATIN ROSUVASTATIN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-04-27 2017-04-10
Actual start date
Estimated end date 2017-06-15
Actual end date 2017-04-24
Shortage status Actual shortage Resolved
Tier 3 Status No No
Company comments
Health Canada comments